Carla Gallenga to Inflammation
This is a "connection" page, showing publications Carla Gallenga has written about Inflammation.
Connection Strength
0.228
-
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1623-1627.
Score: 0.043
-
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020 March-April,; 34(2):333-338.
Score: 0.041
-
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? J Biol Regul Homeost Agents. 2019 May-Jun; 33(3):669-673.
Score: 0.039
-
Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019 Jan-Feb,; 33(1):1-6.
Score: 0.038
-
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. J Biol Regul Homeost Agents. 2018 Mar-Apr; 32(2):195-198.
Score: 0.036
-
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1629-1632.
Score: 0.011
-
Mesenchymal stem cells and IL-37: a powerful combination. J Biol Regul Homeost Agents. 2019 Jul-Aug; 33(4):1019-1022.
Score: 0.010
-
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators. J Biol Regul Homeost Agents. 2018 May-Jun; 32(3):449-454.
Score: 0.009